Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients

Daniel J. Firl, Kazunari Sasaki, Vatche G. Agopian, Andre Gorgen, Shoko Kimura, Wethit Dumronggittigule, John C. McVey, Samuele Iesari, Gianluca Mennini, Alessandro Vitale, Armin Finkenstedt, Simona Onali, Maria Hoppe‐Lotichius, Giovanni Vennarecci, Tommaso M. Manzia, Daniele Nicolini, Alfonso W. Avolio, Salvatore Agnes, Marco Vivarelli, Giuseppe Tisone, Giuseppe M. Ettorre, Gerd Otto, Emmanuel Tsochatzis, Massimo Rossi, Andre Viveiros, Umberto Cillo, James F.

Hepatology Highlights

Omar Y. Mousa, Harmeet Malhi, Nicholas Russo, Arun Jesudian, Joseph F. Pisa, Tasha B. Kulai, Jessica L. Maiers, Enis Kostallari, Nidhi Jalan‐Sakrikar, Zaid H. Tafesh, Brett E. Fortune, Lauren Yang, Daryl T.Y. Lau, Kavitha Nair, Joel Wedd – 27 June 2019

Copper Deficiency in Liver Diseases: A Case Series and Pathophysiological Considerations

Lei Yu, Iris W. Liou, Scott W. Biggins, Matthew Yeh, Florencia Jalikis, Lingtak‐Neander Chan, Jason Burkhead – 26 June 2019 – Copper is an indispensable trace element. It serves as a cofactor for enzymes involved in cellular energy metabolism, antioxidant defense, iron transport, and fibrogenesis. Although these processes are central in the pathogenesis of liver disorders, few studies have attributed them to copper deficiency.

Subscribe to